scholarly article | Q13442814 |
P50 | author | Grażyna Stochel | Q60133056 |
Agnieszka Kyzioł | Q90385466 | ||
Małgorzata Kus-Liśkiewicz | Q91547158 | ||
P2093 | author name string | Anna Regiel-Futyra | |
Manuel Arruebo | |||
Silvia Irusta | |||
Victor Sebastian | |||
P2860 | cites work | Staphylococcus aureus infections | Q28131787 |
Synthesis and anti-fungal effect of silver nanoparticles–chitosan composite particles | Q29248669 | ||
Cytotoxicity and genotoxicity of silver nanoparticles in human cells | Q29615488 | ||
Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria | Q33978543 | ||
Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. | Q34139659 | ||
Antimicrobial effects of silver nanoparticles. | Q34611349 | ||
Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity | Q34763957 | ||
Understanding biofilm resistance to antibacterial agents | Q35058558 | ||
Development of noncytotoxic chitosan-gold nanocomposites as efficient antibacterial materials | Q35077690 | ||
Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles | Q35092075 | ||
Insights into the mode of action of chitosan as an antibacterial compound | Q36746819 | ||
Dynamic protein coronas revealed as a modulator of silver nanoparticle sulphidation in vitro | Q37000085 | ||
Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications | Q37274495 | ||
Chitosan and its antimicrobial potential--a critical literature survey | Q37274768 | ||
An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. | Q37994224 | ||
Antifungal activity and mode of action of silver nano-particles on Candida albicans | Q38499096 | ||
Evaluation of cytotoxic, oxidative stress, proinflammatory and genotoxic effect of silver nanoparticles in human lung epithelial cells. | Q39134446 | ||
Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells | Q39343825 | ||
Cytotoxic effects of gold nanoparticles: a multiparametric study | Q39608760 | ||
Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. | Q39709419 | ||
Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. | Q39867531 | ||
Cytotoxic and mutagenic effects of dental composite materials | Q40485603 | ||
Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties. | Q40955960 | ||
Preparation and characterization of chitosan-silver nanocomposite films and their antibacterial activity against Staphylococcus aureus. | Q45747712 | ||
Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier. | Q46109809 | ||
An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles | Q46120317 | ||
Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds | Q46596562 | ||
Construction, application and biosafety of silver nanocrystalline chitosan wound dressing | Q46787020 | ||
120 years of nanosilver history: implications for policy makers | Q48654454 | ||
Chitosan and silver nanoparticles as pudding with raisins with antimicrobial properties. | Q50036962 | ||
Green synthesis of silver and copper nanoparticles using ascorbic acid and chitosan for antimicrobial applications | Q50451105 | ||
Facile synthesis of Ag and Au nanoparticles utilizing chitosan as a mediator agent. | Q50870683 | ||
Synergistic antibacterial activity of chitosan-silver nanocomposites on Staphylococcus aureus. | Q52608340 | ||
Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. | Q54125111 | ||
The synthesis of chitosan-based silver nanoparticles and their antibacterial activity. | Q54397747 | ||
Non-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activity. | Q54405702 | ||
Electronic structure ofAg2O | Q62677482 | ||
A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus | Q73082483 | ||
Electronic structures of ordered Ag-Mg alloys | Q74406738 | ||
Evaluation of the biocompatibility of a chitosan scaffold in mice | Q77441131 | ||
Silver nanoparticles induce apoptotic cell death in Candida albicans through the increase of hydroxyl radicals | Q83423015 | ||
Formation of gold nanoparticles using amine reducing agents | Q83973914 | ||
P433 | issue | 83 | |
P921 | main subject | biofilm | Q467410 |
P304 | page(s) | 52398-52413 | |
P577 | publication date | 2017-11-13 | |
P1433 | published in | RSC Advances | Q15716379 |
P1476 | title | Development of noncytotoxic silver–chitosan nanocomposites for efficient control of biofilm forming microbes† †Electronic supplementary information (ESI) available: ICP-MS, DLS, FTIR, contact angle measurements, TEM/EDS, cytotoxicity results. See DO | |
P478 | volume | 7 |
Search more.